PSMD1 and adenocarcinoma: Among these, 15 patients (46.9%) were diagnosed with adenocarcinoma and 10 (31.3%) with squamous cell carcinoma, with these frequencies being comparable in the cisplatin + S-1 + radiation therapy group and slightly lower in the other groups.